Year ended December 31, | ||||||
(EUR thousand, except per share data) | Notes | 2016 | 2017 | |||
Net sales | 19 | 597,930 | 737,401 | |||
Cost of sales | (333,430) | (431,506) | ||||
Gross profit | 19 | 264,500 | 305,895 | |||
Operating expenses: | ||||||
Selling, general and administrative | 21 | (91,130) | (99,931) | |||
Research and development | 22 | (91,129) | (92,777) | |||
Total operating expenses | (182,259) | (192,708) | ||||
Result from operations | 19 | 82,241 | 113,187 | |||
Finance income | 3,095 | 1,683 | ||||
Finance expense | (1,096) | (1,799) | ||||
Foreign currency exchange gain (loss), net | 13,032 | (30,546) | ||||
Share in income of investments in associates | 6 | 40,488 | 89,614 | |||
Result from sale of ASMPT shares | 6 | – | 284,898 | |||
Result before income taxes | 137,760 | 457,037 | ||||
Income taxes | 20 | (2,289) | (4,635) | |||
Net earnings from operations, attributable to common shareholders | 135,471 | 452,402 | ||||
Per share data | 23 | |||||
Basic net earnings per share (EUR): | ||||||
From operations | 2.23 | 7.72 | ||||
Diluted net earnings per share (EUR): | ||||||
From operations | 2.21 | 7.63 | ||||
Weighted average number of shares (thousand): | ||||||
Basic | 60,616 | 58,573 | ||||
Diluted | 61,253 | 59,325 |